Increased Plasma Fatty Acid Ethyl Ester Levels Following Inhibition of Oxidative Metabolism of Ethanol by 4-Methylpyrazole Treatment in Human Subjects
- 1 July 2006
- journal article
- research article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 30 (7) , 1126-1131
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Induction of apoptosis by fatty acid ethyl esters in HepG2 cellsFood and Chemical Toxicology, 2005
- Red blood cell fatty acid ethyl esters: a significant component of fatty acid ethyl esters in the bloodJournal of Lipid Research, 2003
- Fatty acid ethyl esters toxic non-oxidative metabolites of ethanol and markers of ethanol intakeFrontiers in Bioscience-Landmark, 2003
- Polymorphism in alcohol‐metabolizing enzymes, glutathione S‐transferases and apolipoprotein E and susceptibility to alcohol‐induced cirrhosis and chronic pancreatitisJournal of Gastroenterology and Hepatology, 2002
- Fomepizole for the Treatment of Methanol PoisoningNew England Journal of Medicine, 2001
- Fomepizole for the Treatment of Ethylene Glycol PoisoningNew England Journal of Medicine, 1999
- Fatty acid ethyl esters in the blood as markers for ethanol intake1996
- Kinetic Interactions Between 4‐Methylpyrazole and Ethanol in Healthy HumansAlcohol, Clinical and Experimental Research, 1996
- Purification of fatty acid ethyl esters by solid-phase extraction and high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Alcohol dehydrogenase polymorphisms and predisposition to alcoholic cirrhosisHepatology, 1993